Showing results (61-70 of 120) with videos related to
Sort By:
Pageof 12
Nuclear Medicine Communications|January 28, 2016
Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastomaSally L George, Nadia Falzone, Sarah Chittenden, et al.European Journal of Cancer (Oxford, England : 1990)|June 22, 2021
Phase 1 dose-escalation and pharmacokinetic study of regorafenib in paediatric patients with recurrent or refractory solid malignanciesBirgit Geoerger, Bruce Morland, Irene Jiménez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2020
Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG ProjectElizabeth Sokol, Ami V Desai, Mark A Applebaum, et al.Journal of Pediatric Hematology/Oncology|December 11, 2013
Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: the Royal Marsden experienceDaniel A Morgenstern, Darren Hargrave, Lynley V Marshall, et al.European Radiology|March 17, 2015
Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot studyKeiko Miyazaki, Neil P Jerome, David J Collins, et al.Pediatric Blood & Cancer|September 13, 2016
Feasibility and applicability of diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging in routine assessments of children with high-grade gliomasFernando Carceller, Neil P Jerome, Keiko Miyazaki, et al.European Radiology|March 23, 2016
Repeatability of derived parameters from histograms following non-Gaussian diffusion modelling of diffusion-weighted imaging in a paediatric oncological cohortNeil P Jerome, Keiko Miyazaki, David J Collins, et al.Pediatric Blood & Cancer|November 18, 2020
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group projectLucas Moreno, Dongjing Guo, Meredith S Irwin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2014
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group DatabaseDaniel A Morgenstern, Wendy B London, Derek Stephens, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Advances in Risk Classification and Treatment Strategies for NeuroblastomaNavin R Pinto, Mark A Applebaum, Samuel L Volchenboum, et al.Pageof 12